Company Overview
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform within the United States, delivering pharmacy and provider services through its clinical and operational infrastructure. The company functions within the broader Healthcare sector, specifically the Health Information Services industry, a classification that reflects its focus on managing patient data, medication distribution, and direct care delivery models. In terms of scale, the enterprise commands a market capitalization of $8.45B and generates annual revenue of $12.91B, supported by a workforce of 23,500 employees. These valuation and revenue figures indicate that the company maintains a significant presence in the market, positioning it as a substantial entity capable of influencing sector dynamics through its extensive service network and substantial capital base.
Financial Health
The company reports a trailing twelve-month revenue of $12.91B with a corresponding net income of $106.35M and an EBITDA of $485.33M. The substantial gap between the total revenue figure and the net income reveals a complex cost structure where operating expenses, including cost of goods sold and administrative costs, consume the majority of top-line revenue, leaving a relatively narrow profit base. Free cash flow stands at $-334,849,888, indicating a current state of cash burn where operational expenditures and capital investments exceed the cash generated from operations, which limits immediate financial flexibility for unplanned strategic initiatives. Three distinct margin metrics further define profitability: the gross margin is 11.8%, the operating margin is 3.0%, and the profit margin is 1.5%. These low margin levels suggest that the business model relies on high volume to achieve profitability, as every percentage point of margin improvement is critical to overall financial performance. Regarding liquidity and leverage, the company holds $88.37M in cash against $2.71B in total debt, resulting in a debt-to-equity ratio of 143.60. This balance sheet configuration indicates a highly leveraged position where debt obligations significantly outweigh available liquid cash reserves. The current ratio of 1.56 suggests that the company possesses sufficient current assets to cover its short-term liabilities, though the margin of safety is moderate given the heavy debt load. Return on equity is recorded at 5.9% and return on assets at 3.3%, metrics that reveal management faces the challenge of generating substantial returns on a capital-intensive asset base while managing significant debt burdens.
Valuation Assessment
Valuation multiples show a trailing P/E ratio of 91.65 and a forward P/E of 22.62. The dramatic difference between these two figures implies that the market expects earnings to expand substantially in the future to justify the current high multiple, suggesting a belief in a significant inflection point in profitability. The price-to-book ratio is 4.78, indicating that the stock trades at a substantial premium relative to the company's net asset value, reflecting investor confidence in intangible assets or future growth potential rather than current book value. Alternative valuation metrics include a price-to-sales ratio of 0.65 and an EV/EBITDA of 24.03. These metrics suggest that while the stock is expensive relative to earnings, it trades at a reasonable multiple of sales and enterprise value relative to earnings before interest, taxes, depreciation, and amortization, providing a different lens on value than the P/E alone. The 52-week high is $44.87 and the 52-week low is $15.48. Based on the provided data points, the specific current trading price cannot be calculated as a percentage of the range without an explicit current price input, but the range defines the volatility envelope within which the asset has traded over the past year. The beta is 2.33, which means the stock exhibits high price volatility relative to the broader market, moving more than twice as much as the average market index in response to general market fluctuations.
Growth & Income
Revenue growth is recorded at 29.3% year-over-year while earnings growth is recorded at 338.3% year-over-year. Earnings are growing significantly faster than revenue, which implies a potential optimization of cost structures, a one-time gain contributing to the bottom line, or a step-change in operational efficiency that is not yet fully reflected in the top line. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests its earnings back into the business to fund growth initiatives, debt repayment, or operational expansion rather than distributing cash to shareholders. This reinvestment strategy aligns with the company's heavy debt load and negative free cash flow, prioritizing long-term operational scaling over immediate income distribution to investors. The overall growth and income profile is characterized by aggressive earnings expansion and zero dividend distribution, focusing entirely on capital appreciation potential through operational scaling and market share gains.